High serum endothelin-1 level is associated with poor response to steroid therapy in childhood-onset nephrotic syndrome

Abstract EN

Nephrotic syndrome (NS) is one of the most common kidney diseases seen in children.

It is a disorder characterized by severe proteinuria, hypoproteinemia, hyperlipidemia, and generalized edema resulting from alterations of permeability at the glomerular capillary wall.

Endothelin-1 (ET1) has a central role in the pathogenesis of proteinuria and glomerulosclerosis and has a role in assessment of the clinical course of NS in children.

This study aims to investigate the relationship between ET1 serum level and the response to steroid therapy in children with primary NS.

Serum ET1 levels were evaluated in 55 children with NS.

They were classified into two groups: 30 patients with steroid-sensitive NS (SSNS) and 25 patients with steroid-resistant NS (SRNS).

The SSNS group was further divided into infrequent-relapsing NS (IFRNS) and steroid-dependent NS (SDNS), while the SRNS group was subdivided into two groups according to renal pathology.

ET1 levels were significantly higher in the SRNS group (52.5 ± 45.8 pg/dL) compared to the SSNS group (18.3 ± 17 pg/dL) (P <0.001).

Furthermore, ET1 levels were significantly higher in SDNS (54.3 ± 18.6) compared to IFRNS (11.9 ± 7.8, P = 0.001).

There was no statistically significant difference in ET1 levels between minimal change disease group and focal segmental glomerulosclerosis group, (P = 0.28).

Serum ET1 can be considered as a predictor for response to steroid therapy.